PHATHOM PHARMACEUTICALS, INC. Adjustments to Additional Paid in Capital, Warrant Issued
PHATHOM PHARMACEUTICALS, INC. (PHAT) reported Adjustments to Additional Paid in Capital, Warrant Issued of $1.29 million for the 12-month period ending 2021-12-31, per its 10-K filed 2023-02-28.
Discontinued
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2023-02-28
- PHATHOM PHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2021-09-30 was $1.29M.
- PHATHOM PHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2021 was $1.29M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|
| 2021-12-31 | $1.29M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $1.29M 10-Q/A · filed 2022-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 |